The PubMed record presents an article entitled "Biologically optimized 3D range modulators for fast conformal carbon ion therapy: in vitro validation, treatment planning, and robustness analysis." The title indicates the work addresses the design and evaluation of 3D range modulators that are biologically optimized to support fast conformal carbon ion therapy. The study claims to cover three principal areas: laboratory (in vitro) validation, treatment planning, and robustness analysis.
The article lists multiple authors with primary affiliations at Heidelberg-based institutions. Key affiliations named in the PubMed entry include the Clinical Cooperation Unit Translational Radiation Oncology at the National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), the German Cancer Research Center (DKFZ), the Department of Physics and Astronomy at Heidelberg University, the Medical Faculty at Heidelberg University, the Department of Radiation Oncology and Heidelberg Institute of Radiation Oncology (HIRO) at Heidelberg University Hospital, and the Heidelberg Ion-Beam Therapy Center (HIT).
This work was published in Phys Med Biol. Citation metadata in the PubMed record are: 2026 Sep 2;71(17). PubMed PMID 42624158. DOI 10.1088/1361-6560/ae9c86. The PubMed entry supplies the full author list and affiliations alongside the citation identifiers.
According to the title and metadata available on PubMed, the manuscript focuses on creating and evaluating biologically optimized three-dimensional devices—range modulators—intended to deliver fast, conformal dose distributions with carbon ion beams. The title explicitly lists three evaluation domains: an in vitro validation, treatment-planning investigations, and a robustness analysis. These domains imply an experimental bench validation, dosimetric or plan comparison work, and sensitivity assessments under likely perturbations, although precise methods and endpoints are not provided in the PubMed excerpt.
The PubMed record states that an in vitro validation was performed, but it does not include the abstract or methods that would describe the cell or phantom models used, experimental setup, biological endpoints measured, or numerical outcomes. Therefore, specific experimental design, assay types, biological response measures, and results were not reported in the source text supplied here.
The title indicates treatment planning work was part of the study, likely to evaluate how the proposed 3D range modulators integrate into clinical planning workflows for carbon ion therapy and to assess resulting dose conformity. However, the PubMed excerpt does not include details such as planning systems used, patient or phantom datasets, dosimetric metrics compared (for example conformity index, homogeneity, or organ-at-risk sparing), nor any quantitative plan comparisons. Those details were not reported in the provided source content.
A robustness analysis is listed among the study components in the title. Robustness analyses typically probe the sensitivity of dose distributions to uncertainties (for instance setup, range, or motion), but the PubMed entry does not report which uncertainties were tested, what metrics were adopted, or the observed sensitivity patterns. Specific robustness methodology, scenarios, and results are not present in the supplied record.
The PubMed page excerpt used as the source for this rewrite supplies comprehensive bibliographic metadata (title, author list, affiliations, journal, publication date, PMID, DOI) but does not include the abstract, full methods, results, figures, tables, or the authors’ conclusions. Consequently, this summary refrains from inventing experimental parameters, numerical outcomes, or conclusions that are not present in the source.
For full experimental details, quantitative findings, statistical analyses, and the authors’ interpretation, consult the full-text article via the DOI link (10.1088/1361-6560/ae9c86) or the publisher’s page. The PubMed record itself points to full-text links but the excerpt provided here did not contain the article abstract or content.
Based on the record title and metadata, the manuscript is likely of interest to teams working on particle therapy delivery devices, biological optimization of range modulation, and integration of novel modulator hardware into treatment planning and quality assurance processes for carbon ion therapy. To assess clinical applicability, dosimetric benefits, biological impact, and operational robustness, readers will need to review the full text for experimental protocols, treatment-planning workflows, robustness scenarios, and measured outcomes.
Note: The PubMed excerpt used as the source did not include the article abstract or experimental data; statements above summarize only what is explicitly present in the supplied record and identify where details were not reported.